Vaccine Technologies for Veterinary Viral Diseases : Methods and Protocols (Methods in Molecular Biology) (2ND)

個数:

Vaccine Technologies for Veterinary Viral Diseases : Methods and Protocols (Methods in Molecular Biology) (2ND)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 306 p.
  • 言語 ENG
  • 商品コード 9781071621707
  • DDC分類 636.0895372

Full Description

This second edition includes a collection of antigen production and delivery strategies for vaccine development in veterinary species. New and updated chapters guide readers through protocols for antigen production, experimental antigen delivery and the analysis of immune responses upon vaccination. Written in the format of the highly successful Methods in Molecular Biology series, each chapter includes an introduction to the topic, lists necessary materials and reagents, includes tips on troubleshooting and known pitfalls, and step-by-step, readily reproducible protocols.

 Authoritative and cutting-edge, Vaccine Technologies for Veterinary Viral Diseases: Methods and Protocols, Second Edition aims to be a useful and practical guide to researches to help further their study in this field. 

Contents

An overview of veterinary viral diseases and vaccine technologies.- Production and purification of candidate subunit vaccines by IC-tagging protein encapsulation.- Elastin-like polymers as nanovaccines: protein engineering of self-assembled, epitope-exposing nanoparticles.- Display of heterologous proteins in Bacillus subtilis biofilms for enteric immunization.- Production of influenza H5 vaccine oligomers in plants.- DNA vaccines in pigs: from immunization to antigen identification.- Use of foot-and-mouth disease virus non-coding synthetic RNAs as vaccine adjuvants.- Evaluation of innate lymphoid cells and dendritic cells following viral vector vaccination.- Generation of replication deficient human adenovirus 5 (Ad5) vectored FMD vaccines.- Recombinant modified vaccinia virus Ankara development to express VP2, NS1, and VP7 proteins of Bluetongue virus.- Cloning strategies for the generation of recombinant capripoxvirus through the use of screening and selection markers.- Using Rift Valley fever virus as a vector platform for the expression of ruminant disease antigens.- Generation and characterization of single-cycle infectious canine Influenza A Virus (sciCIV) and its use as vaccine platform.- Reverse genetics for influenza A and B viruses driven by swine polymerase I promoter.- Analysis of the cellular immune responses to vaccines.